| Financial Year |
March 31 2023 |
| Monetary Funds |
63,417,207.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,110,000.00 |
| Accounts Receivable |
14,906,438.63 |
| Advances to Suppliers |
30,270,386.31 |
| Other Receivables |
1,810,745.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,117.10 |
| Inventories |
30,576,119.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,394,370.24 |
| Total Current Assets |
167,485,267.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
65,244.54 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
215,747.34 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
497,261.22 |
| Total Assets |
167,982,528.74 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,083,792.15 |
| Accounts Received In Advance |
174,014.90 |
| Employee Compensation Payable |
209,757.94 |
| Taxes Payable |
29,528.54 |
| Interest Payable |
2,740,910.57 |
| Dividend Payable |
-- |
| Other payables |
7,908,878.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
218,525.78 |
| Other Current Liabilities |
79,944,750.00 |
| Sub-Total of Current Liabilities |
93,570,403.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,282,767.02 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,282,767.02 |
| Total Liabilities |
95,853,170.46 |
| Paid-In Capital(Or Share Stock) |
328,861,441.00 |
| Capital Surplus |
448,669,081.78 |
| Surplus Reserve |
46,796,342.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-758,644,169.31 |
| Minority Stockholder's Interest |
6,446,661.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
65,682,696.31 |
| Owner's Equity（Stockholder's Equity） |
72,129,358.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
167,982,528.74 |
